Introduction Approximately 30% of all patients with stroke show visuospatial neglect (VSN). Currently, visual scanning therapy (VST) is applied in clinical settings to attenuate neglect symptoms. VST builds on the premise that eye movements to the affected hemifield lead to a concurrent shift of visual attention. Congruent movements with different effectors of the motor system, for example, eye and hand, can produce an even larger boost of attention compared with a single effector. This congruency principle may produce a powerful bias in the motor system, which may counteract the pathological biases in the attentional system of neglect patients. Therefore, an intervention with congruent eye and hand movements may result in greater attenuation of neglect compared with an intervention with single eye movements as applied in standard VST. The current randomised controlled trial will investigate the beneficial effects of this updated version of VST by comparing changes in performance on standard neuropsychological neglect tasks and severity of neglect in activities of daily living. Methods and analysis Thirty VSN patients in the subacute phase poststroke onset will be randomly assigned to one of two groups: congruent eye and hand movement training (experimental group) versus standard VST (control group). Each patient will receive 10 sessions of training, 30 min each, within 2 weeks. Performance on standard neuropsychological neglect tasks, a visual discrimination task, severity of neglect in ADL and eye movement characteristics before and after intervention will be compared for and between both groups. Ethics and dissemination This study has been approved by the ethical committee of the University Medical Centre Utrecht. All subjects will participate voluntarily and will give written informed consent. Results of this study will be published in peer-reviewed scientific journals and presented at international conferences. trial registration number NTR7005
IntroduCtIon
Visuospatial neglect (VSN) is defined as the failure to report, respond to or orient to stimuli presented in the contralesional visual field in the absence of motor or sensory defects. 1 The core of this disorder reflects lateralised impairments of attention: there is a strong bias to allocate attention to the ipsilesional visual field, whereas little attention is allocated to the contralesional visual field. [2] [3] [4] Patients with neglect need more help in daily life activities (ADL) compared with patients without neglect 5 6 and are less likely to being discharged home after admission to rehabilitation. 7 While some spontaneous recovery may occur, about 40% of all VSN patients still show symptoms of neglect 1 year poststroke. 8 With a high incidence after stroke (~30%) and a slow and more attenuated recovery pattern, it is important to develop new and more effective treatments for neglect.
Visual scanning therapy (VST) is currently the most frequently used clinical treatment to attenuate symptoms of VSN. Patients are trained to make systematic eye movements to their affected hemispace. An important assumption for the efficacy of this treatment is a concurrent shift of attention coupled to the eye movement. According to the premotor theory of attention (PMT), attention and the motor system are tightly linked. PMT holds that planning a movement is both necessary and sufficient for attentional orienting. 9 Planning an eye movement to a spatial location results in a shift of attention to that location before the eye movement is executed. This shift is known as a 'presaccadic' shift of attention. 10 The 'motor system' is not a single system, however, but a collection of different effector systems, such as the eye movement system and the hand movement system. Indeed, planning a hand movement (without moving the eyes) is also preceded by a shift of attention to that location resulting in a 'prepointing' shift of attention. Each effector system might therefore contribute differently and potentially independently to attentional orienting. 11 Jonikaitis and Deubel investigated this hypothesis and confirmed that both effector systems (hand movements and eye movements) can independently produce a shift of attention. 12 Importantly, they showed that planning two movements at the same time to the same spatial location (congruent eye-hand movements) results in an additional boost of attention to that location compared with planning a movement with a single effector. These results in healthy controls suggest new approaches to treatment for patients with asymmetric attentional deficits such as VSN. Congruence between different effector systems should produce a powerful bias in the motor system which can counteract pathological biases in the attentional system. Training patients to adopt this principle of congruence outside of the laboratory might result in beneficial effects during various activities in daily life.
Therefore, the current study will evaluate the surplus value of an experimental congruent movement training (CMT: simultaneous eye and hand movements to the same location in the affected hemifield). Results will be compared with a control training with single eye movements, that is, VST. If congruent movement training appears to be more effective than VST in the reduction of VSN symptoms, it might be implemented in the clinic.
MEthodS And AnAlySIS design
A new training approach, CMT, will be compared with standard VST in this randomised controlled trial. Since patients are admitted to the rehabilitation centre, which aim to discharge patients from the rehabilitation centre as soon as possible, we chose to compare two independent groups (A vs B) rather than a cross-over design (AB-BA), which will have led to a large dropout. At the time of the neuropsychological screening to assess whether a patient has VSN, it is still unknown whether a patient can be included in the study and which treatment he/she will receive if he/she can be included. After inclusion, in chronological order, VSN patients will be randomly assigned to one of two groups, based on a predetermined list generated using Matlab, that has paired one of the training variants to a participant number. Patients are not explicitly informed about the nature of their treatment (ie, whether they receive the experimental CMT or control VST treatment). The nurses who assess the Catherine Bergego Scale (CBS) are blinded to training variant. The researchers who administer the training and the tests are not blinded, since they have to explain the training and tests. To minimise any (unintended) bias, the same task instructions are read aloud for each patient before each test. All data are collected and saved automatically by the computer program so that no changes can be made after task completion. Outcome measures of the group of VSN patients who receive CMT (n=15) will be compared with the group of VSN patients who are trained with VST (n=15). All patients will receive 10 sessions of training, 30 min per session, parallel to their standard rehabilitation programme.
Baseline performance on all tasks will be collected for each VSN patient on two separate days prior to training and compared with the performance after training (figure 1).
baseline performances
Since we also include new (secondary) outcome measures and tests (eye tracking, cookie theft picture for free exploration, visual discrimination task, virtual reality), we need to compare the data of the neglect patients to stroke patients without neglect and healthy control to study whether baseline performance (1) deviates from normal range (2) is stroke or neglect specific. In addition, the control data allow us to examine whether performance after training change to values that can be considered as normal on these tasks. Therefore, only baseline measurements will be collected for a patient control group and healthy control group, and these two groups will not receive any training (table 1) . Performance on all outcome measures of both VSN intervention groups will be compared with the performance of a patient control group (stroke patients without VSN, n=15) and age-matched healthy controls (n=15).
Subjects
Patients will be recruited in De Hoogstraat Rehabilitation and De Parkgraaf Rehabilitation between May 2018 and January 2020. VSN is assessed during a neuropsychological screening which is 'care as usual' for all patients admitted to De Hoogstraat and De Parkgraaf Rehabilitation Centre. VSN patients are included (in chronological order) if they (1) are clinical diagnosed with symptomatic stroke (left or right ischaemic or intracerebral haemorrhagic lesion), (2) show signs of VSN based on one of the neuropsychological VSN tests (shape cancellation, line bisection, Catherine Bergego Scale), (3) are between 18 and 85 years of age, (4) have sufficient comprehension and communication, (5) have sufficient motivation to participate and (6) give written informed consent.
The patient control group will have no VSN based on the neuropsychological tests. Healthy control subjects will be included if they have (1) no history of neurological disorders, (2) are between 18 and 85 years of age, (3) sufficient comprehension and communication, (4) sufficient motivation to participate and (5) written informed consent. Exclusion criteria for these groups are (1) interfering disorders, (2) expected discharge <4 weeks and (3) mentally or physically unable to participate. The neuropsychologist and rehabilitation physician are consulted regarding the exclusion criteria.
Congruent movement training (experimental treatment)
CMT is a new approach for treatment of VSN. Patients are instructed to make simultaneous eye and hand movements to a location in their affected hemifield. This is accomplished by performing a game-like task on a computer with touchscreen (figure 2, left pane). The pointing movements are made with the contralesional hand (the ipsilesional hand in case of contralesional paresis). Patients have to match a coloured grid (template grid) that is shown at the top corner of the screen in their affected hemifield. An empty grid is placed beneath the coloured grid (target grid). The patient has to press a button in the ipsilesional hemifield to replace this button with a new coloured item. After appearance of the coloured item in the ipsilesional hemifield, the template grid will flash to attract attention. Subsequently, the patient has to point at a location on the empty grid where he/she wants the coloured item to be placed. The coloured item in the ipsilesional hemifield then will move to the location in the empty grid and the button will appear again. A new coloured item will appear at the ipsilesional field after pressing the button. This task requires repetitive pointing from the ipsilesional side of the screen to specific locations in the affected hemifield and needs to be accompanied by eye movements to the same locations to accurately place the coloured item in the empty grid. Different variations of the task will be available, for example, where a template grid of different shapes (squares, circles and triangles) need to be matched. Patients receive sessions of 30 min, each working day, during 2 weeks.
Visual scanning therapy (control treatment)
Patients are instructed to make eye movements to the affected hemifield to detect a specific stimulus. Importantly, no pointing movements will be made during this training. To make this task comparable to CMT, two coloured grids (figure 2, right pane) are shown: one at the ipsilesional side (the template grid) and one located in the affected hemifield of the patient (the target grid). The same grids and locations for the target grid are used as those used during CMT. The target grid will flash at random timings to attract attention. The patient has to report verbally if and how many elements of the target grid are different from the template grid. The experimenter will note the response. Different variations of the task will be available (eg, match forms). Patients receive sessions of 30 min, each working day, during 2 weeks.
Study parameters Demographical and stroke-related parameters
The demographic factors age, gender, handedness will be registered at baseline. Also, type of stroke, hemisphere, date of stroke, stroke history (recurrent/first), Barthel Index, 13 Motricity Index, 14 15 Montreal Cognitive Assessment 16 and Stichting Afasie Nederland test 17 will be registered at baseline.
Main study parameters
Changes in performance (post-training-baseline) on standard neuropsychological VSN tests, that is, the shape cancellation (number of omissions) and line bisection task (deviation from centre) will be calculated. Also, a visual discrimination task will be used to study the presaccadic shift of attention 18 before and after training. In this 2-alternative forced choice experimental task, an 'E' or inverted 'E' is presented presaccadically in the left or right hemifield and needs to be reported. Performance (% correct responses) is suggested to reflect the amount of attention directed to the location of the eye movement and will be calculated per hemifield location. Finally, the CBS, administered by the nurse, will be used to assess changes in ADL. The CBS is an observation list designed to assess the presence and severity of VSN in 10 daily activities. 19 20 This includes motor components of VSN. For all four primary outcomes, beneficial effects after CMT will be compared with effects after standard VST.
Secondary study outcomes
To study visual exploration patterns, eye movements will be recorded during an image exploration task. Patients are instructed to look at and describe the 'Cookie theft' picture. 21 The number of reported items, search strategies 22 23 and After pressing the button that is placed in the ipsilesional hemifield (indicated by dashed rectangle), a coloured item will appear which needs to be placed at the correct location inside the target grid to match the template grid. Right pane: visual scanning therapy. The target is located at the top or at the bottom (indicated by dashed grid) of the affected hemifield. To report how many items are different, eye movements need to be made between the ipsilesional template grid and the contralesional target grid. Note, this figure is an example for left-sided visuospatial neglect.
the eye movement behaviour (eg, number of fixations) will be obtained.
To study behaviour in a more dynamic situation, patients will perform a shopping task in a virtual supermarket. This supermarket will be administered with an HTC Vive head-mounted display. Eye movements are recorded with build-in eye trackers. With use of the consoles, the patient is able to navigate within the supermarket. Sound is presented through regular headphones. The patients have to purchase a list of products (shopping list shown prior to start) and be alert to announcements via the headphones. The assignment is to find the products on the shopping list before the supermarket closes and walk by the check-out counters to complete the task. Outcomes are number of products found, distance covered, eye movement patterns while searching for products or during navigation.
Also, performance during training (correct responses, time needed to complete trial, number of pointing movements and eye movement characteristics) will be evaluated.
Finally, a computerised visual field test will be used to screen for visual field defects.
For all secondary outcomes, beneficial effects after CMT will be compared with effects after standard VST. Statistical analyses and sample size calculation Repeated measures analyses (analysis of covariance (ANCOVA)) will be performed, with session (baseline post-training) as within-subject variable and treatment (CMT, VST) as between-subject variable. Level of education (Verhage score) will be added as covariate. Performance on all primary and secondary outcome measures will be compared. Patients are randomly assigned to one of the two groups, so we expect that both groups will be comparable in terms of severity of neglect. A difference in severity of neglect between the two groups will be based on chance. However, if there is a difference in severity of neglect, we will correct for that to address our main research question.
In addition, we will conduct additional analysis to relate severity of neglect with training potential in general.
To explore the performance on the new outcome measures (eye tracking data: number of fixations, fixation duration, direction of first saccade) and tasks (cookie theft and virtual supermarket), we compare baseline performances of the neglect patients to the patient and healthy control groups using parametric t-tests or non-parametric tests in case of non-normal distributed data. If these data are deviating from the control groups, we conduct additional analyses, similar as performed for the primary outcome measures (repeated measures analyses (ANCOVA), with session (baseline post-training) as within-subject variable and treatment (CMT, VST) as between-subject variable) to test whether these new outcome measures improve more during CMT than VST training. The false discovery rate approach will be used to correct for multiple comparisons.
We performed an a priori power analysis (G-Power V.3.1) to calculate the sample size. Effect sizes reported in literature vary considerably among studies, ranging from 0 to 2.84, with the highest effect size for combined training methods. A study by Polanowska et al 24 While both study designs and training paradigms are very comparable to our design and training, their amount of training was a bit higher. Therefore, we are more conservative and chose a Cohen's D of 1. A power analysis with power set to 0.8 and alpha set to 0.05 estimated the sample size at 14 patients per group (28 in total) for sufficient statistical power.
Patient and public involvement
Feedback of the patients about the training itself will be used to make the training more appealing, without changing the integrity of the design. Patients and public will not be directly involved in the study design and conducting the study. After study completion, all patients will receive an overview of the main study results.
EthICS And dISSEMInAtIon
All subjects will participate voluntarily and will give written informed consent after all information about the study protocol is provided via the information letter and by the researchers.
The results of this study will be published in peerreviewed scientific journals and presented at international conferences.
Open access dISCuSSIon VST is widely used to ameliorate symptoms of visuospatial VSN. Still, the efficacy of VST is variable and not all VSN patients benefit from this training. 26 Therefore, the development of new and more effective treatments is important. Recent studies on congruent motor movements in healthy subjects suggest new approaches to treatment; the more effectors of the motor system that agree on the action endpoint, the more attention is allocated to that location. We translated this principle by updating standard VST. A training with congruent eye and hand movements should increase attention to the affected hemifield to a larger extent than a training with single eye movements, as applied during VST. This relatively simple update of standard VST can easily be implemented if shown to be more effective.
We aim to investigate the surplus value of congruent movement training in a randomised design and collect a range of different outcome measures, including eye movement data during all tasks. Eye movement data in clinical tasks may provide additional (objective) insights in underlying problems after stroke, for example, the distribution of visual attention.
A potential pitfall of the study might be that patients receive our training parallel with their standard rehabilitation programme. As patients are in the subacute phase poststroke onset, we expect that almost all patients will show some progress due to neurobiological recovery. 8 27 28 A second pitfall might be the relative low amount of training hours. We chose to study the intervention in a rehabilitation centre, with other therapies, in the subacute phase poststroke onset, since this is the setting in which the intervention will be implemented if shown to be more effective than standard VST.
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